Lung Cancer
Conference Coverage
Osimertinib improves survival in advanced NSCLC
BARCELONA – Osimertinib is the first TKI to show a survival advantage over another in advanced non–small cell lung cancer, FLAURA investigators...
Article
Lung Cancer in the VA at a National Level
Conference Coverage
Mediastinal Staging for SBRT in Early NSCLC: Should it be Stratified by Tumor Size and Location?
Conference Coverage
VHA-Wide Automated Assessment of EGFR Mutation Testing in Advanced Stage, Non-Squamous, Non-Small Cell Lung Cancer (nsNSCLC)
Conference Coverage
Outcomes After Stereotactic Ablative Radiotherapy (SABR) of Early Stage Non-Small Cell Lung Cancers Without Biopsy Proven Disease
Conference Coverage
New IASLC declaration targets tobacco use among cancer patients
BARCELONA – The IASLC has released a new declaration encouraging physicians to screen all cancer patients for tobacco use and to provide tobacco...
